Analysis on the Effect of Early Screening and Safe Management of Dysphagia in Scleroderma Patients

Abstract

Objective: To analyze the effect of early screening and safe management of dysphagia in scleroderma patients. Methods: From January 2016 to January 2020, a randomized controlled trial was performed with scleroderma patients (n = 42) who were diagnosed as scleroderma. In intervention group, the participants are accepted early screening and safe management of swallowing disorders. The participants of control group are accepted common nursing service. Result: the 48.84% of participants have problems in swallowing process, most participants provide assessment of level 2 of WST. In swallowing test assessment, more participants think they feel obstruction when eating steamed bread. The accident aspiration pneumonia has higher risk than that of aspiration pneumonia in two group (10.00% vs 3.75% & 37.50% vs 23.75%). In research of swallowing function treatment, most participants of intervention group are basic recovery in treatment outcome, the control group have most invalid assessment in treatment outcome. Conclusion: the early screening and safe management of dysphagia can efficacy improve scleroderma dysphagia of scleroderma patients. In dysphagia problem, the scleroderma patients have higher risk of accident aspiration, and the early screening and safe management of dysphagia can improve problems of accident aspiration and aspiration pneumonia. Additionally, the early screening and safe management of dysphagia have strong effect for dysphagia.